Literature DB >> 10482589

Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without effect.

L C Dupuy1, S Dobson, V Bitko, S Barik.   

Abstract

The major site of in vitro phosphorylation by casein kinase 2 (CK2) was the conserved Ser(232) in the P proteins of human, bovine, and ovine strains of respiratory syncytial virus (RSV). Enzymatic removal of this phosphate group from the P protein instantly halted transcription elongation in vitro. Transcription reconstituted in the absence of P protein or in the presence of phosphate-free P protein produced abortive initiation products but no full-length transcripts. A recombinant P protein in which Ser(232) was mutated to Asp exhibited about half of the transcriptional activity of the wild-type phosphorylated protein, suggesting that the negative charge of the phosphate groups is an important contributor to P protein function. Use of a temperature-sensitive CK2 mutant yeast revealed that in yeast, phosphorylation of recombinant P by non-CK2 kinase(s) occurs mainly at Ser(215). In vitro, P protein could be phosphorylated by purified CK1 at Ser(215) but this phosphorylation did not result in transcriptionally active P protein. A triple mutant P protein in which Ser(215), Ser(232), and Ser(237) were all mutated to Ala was completely defective in phosphorylation in vitro as well as ex vivo. The xanthate compound D609 inhibited CK2 but not CK1 in vitro and had a very modest effect on P protein phosphorylation and RSV yield ex vivo. Together, these results suggest a role for CK2-mediated phosphorylation of the P protein in the promoter clearance and elongation properties of the viral RNA-dependent RNA polymerase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482589      PMCID: PMC112856          DOI: 10.1128/JVI.73.10.8384-8392.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein.

Authors:  K Juhasz; S S Whitehead; P T Bui; J M Biggs; J E Crowe; C A Boulanger; P L Collins; B R Murphy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus.

Authors:  K P Tolley; A C Marriott; A Simpson; D J Plows; D A Matthews; S J Longhurst; J E Evans; J L Johnson; P A Cane; V B Randolph; A J Easton; C R Pringle
Journal:  Vaccine       Date:  1996-12       Impact factor: 3.641

3.  Mutagenesis and gene fusion by megaprimer PCR.

Authors:  S Barik
Journal:  Methods Mol Biol       Date:  1997

Review 4.  Basic mechanisms of transcript elongation and its regulation.

Authors:  S M Uptain; C M Kane; M J Chamberlin
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

5.  Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.

Authors:  P L Collins; M G Hill; J Cristina; H Grosfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

6.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication.

Authors:  Q Yu; R W Hardy; G W Wertz
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

8.  Interactions between a minimal protein serine/threonine phosphatase and its phosphopeptide substrate sequence.

Authors:  T Ansai; L C Dupuy; S Barik
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

9.  RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.

Authors:  H Grosfeld; M G Hill; P L Collins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Phosphorylation of Ser232 directly regulates the transcriptional activity of the P protein of human respiratory syncytial virus: phosphorylation of Ser237 may play an accessory role.

Authors:  S Barik; T McLean; L C Dupuy
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

View more
  25 in total

1.  Evidence that the respiratory syncytial virus polymerase is recruited to nucleotides 1 to 11 at the 3' end of the nucleocapsid and can scan to access internal signals.

Authors:  Vanessa M Cowton; Rachel Fearns
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Mutational analysis reveals a noncontractile but interactive role of actin and profilin in viral RNA-dependent RNA synthesis.

Authors:  Mary Harpen; Tiasha Barik; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

Review 3.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

4.  Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA.

Authors:  E Burke; N M Mahoney; S C Almo; S Barik
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 5.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

6.  Rotavirus NSP5: mapping phosphorylation sites and kinase activation and viroplasm localization domains.

Authors:  Catherine Eichwald; Fulvia Vascotto; Elsa Fabbretti; Oscar R Burrone
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity.

Authors:  Stephen W Mason; Erika Aberg; Carol Lawetz; Rachel DeLong; Paul Whitehead; Michel Liuzzi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 8.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Akt plays a critical role in replication of nonsegmented negative-stranded RNA viruses.

Authors:  Minghao Sun; Sandra M Fuentes; Khalid Timani; Dengyun Sun; Chris Murphy; Yuan Lin; Avery August; Michael N Teng; Biao He
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease.

Authors:  Richard Bannister; Deborah Rodrigues; Edward J Murray; Carl Laxton; Mike Westby; Helen Bright
Journal:  Virol J       Date:  2010-09-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.